(Updated - September 22, 2026 4:09 PM EDT)

Wedbush analyst Robert Driscoll downgraded Compass Therapeutics (NASDAQ: CMPX) from Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE